ReportsWeb.com has announced the addition of the “Global Asthma Therapeutics Market Size Status and Forecast 2025”, The report classifies the global Asthma Therapeutics Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
The asthma therapeutics market is estimated to represent a global market of USD 20.1 billion by 2017 with growth rate of 1.9%. Key drivers of the market include rising prevalence of asthma and other respiratory disorders. As per the World Health Organization (WHO), more than 235 million people suffer from asthma globally. Around 3,38,000 deaths were reported in 2015 and most deaths occur among older adults. Further, introduction of technologically advanced products and rising awareness levels about these disorders is anticipated to drive the market growth. Rising research in the field of biologics for asthma treatment is seen as most promising opportunity. Biologics targeting pro-inflammatory cytokines and other inflammatory mediators may be of therapeutic benefit. However, expiry of leading branded drugs such as Singulair (montelukast sodium), Symbicort (budesonide/formoterol fumarate), Advair (fluticasone propionate/salmeterol xinafoate), and Xolair (omalizumab) is anticipated to hamper the market growth.
The global Asthma therapeutics market is segmented on the basis of drug class, product, route of administration and region. On the basis of drug class, the market is segmented into anti- inflammatory, bronchodilators and combination therapy. Combination therapy dominated the market share owing to its high adoption rates and utilization. Anti- inflammatory drugs are expected to witness market growth owing to R&D developments pertaining to biologics. Patent expiration of anti- inflammatory drugs during the forecast period will have impact on the revenue generation. Anti- inflammatory segment is expected to witness the fastest market growth.
Request a Free Sample Copy@ http://www.reportsweb.com/inquiry&RW00011327816/sample
Geographically, the market is represented as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America dominated the overall asthma therapeutics market in terms of revenue share in 2014 at over 50.0%. The escalated incidence rate of asthma, increased awareness levels pertaining to treatment options, and the rising adoption of inhaled therapeutics are some of the major factors attributing the largest revenue share of this region. The European market is set to witness steady growth mainly due to the presence of a considerably developed pharmaceutical industry and the significant demand for asthma-related therapeutics. With the increasing geriatric population, susceptible to acquire respiratory conditions, such as asthma, will further support to the growth of regional market in the U.S.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY DRUG CLASSS
MARKET, BY PRODUCTS
MARKET, BY ROUTE
MARKET, BY REGION
Rest of the World
MARKET, BY COUNTRY
Further Breakdown of The North America Market
Further Breakdown of The Europe Market
Rest of Europe
Further Breakdown of The APAC Market
Rest of APAC
Further Breakdown of The Rest of the World Market
Middle East and Africa
Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011327816/buying
Teva Pharmaceutical Industries Ltd.
Complete report is available@ http://www.reportsweb.com/asthma-therapeutics-market-analysis-and-forecast-report-2018-2025
Patient Handling Equipment Market, By Products (Wheelchairs, Medical Scooters, Mechanical Scooters, Non-Mechanical Scooters, Ambulatory Aids and Other Patient Handling Equipment), By Care Type (Critical Care, Fall Prevention, Bariatric Care, Wound Care and Other Care Type), By End Use (Home Care, Elderly Care and Hospital Settings) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2018 – 2025
By sameer joshi